NYSE:CVM
CEL-SCI Corporation Stock News
$1.23
-0.0400 (-3.15%)
At Close: May 24, 2024
CEL-SCI Corporation to Present at The LD Micro Main Event (XII)
12:00am, Friday, 06'th Dec 2019Cel-Sci is publicly upbeat about a cancer drug. Privately it tried to sell stock
06:10pm, Thursday, 24'th Oct 2019
Trying to sell stock now on the down-low reveals a harsher truth about Cel-Sci and is an ominous tell for the fate of its immunotherapy.
'Cel-Sci is publicly upbeat about its cancer drug. Privately it's trying to sell stock' -STAT News' Adam Feuerstein
12:00am, Thursday, 24'th Oct 2019Bearish CEL-SCI Article Ignored Scientific Evidence And Misinterpreted Multikine's Clinical Trial Design
12:00am, Monday, 14'th Oct 2019Cel-Sci hasn't been upfront on its cancer drug. Time for some truth-telling
08:01pm, Monday, 07'th Oct 2019
Some myths and facts about a Phase 3 clinical trial involving an immunotherapy for head and neck cancer owned by the tiny biotech Cel-Sci.
